Medical Bulletin 16/May/2023 Isra Zaman16 May 2023 4:15 PM ISTHere are the top medical news for the day:How both metabolically healthy and unhealthy ‘forms’ of obesity increase risk of various obesity-related...
Roche blood cancer drug Columvi gets EMA panel recommendation for EU approval Ruchika Sharma28 April 2023 5:26 PM ISTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
Previous cancer linked to long term heightened risk of cardiovascular disease Dr. Kamal Kant Kohli27 April 2023 8:00 PM ISTCancer survivors may be at long term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk factors,...
Medical Bulletin 19/April/2023 Isra Zaman19 April 2023 4:00 PM ISTHere are the top medical news for the day:Vitamin D may play a role in prostate cancer disparities: StudyNew research from Cedars-Sinai Cancer...
Most-accurate tools to research deadliest blood cancer created Isra Zaman19 April 2023 9:15 AM ISTAML is a fast-growing cancer with only a 29 percent survival rate. It has often already spread widely in the bone marrow and blood by the time it's...
Medical Bulletin 14/April/2023 Isra Zaman14 April 2023 3:30 PM ISTHere are the top medical news for the day:New target identified that may prevent blood cancerMore than 10% of older adults develop somatic...
New target identified that may prevent blood cancer Isra Zaman14 April 2023 9:00 AM ISTMore than 10% of older adults develop somatic (non-inherited) mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal...
AbbVie plan to withdraw accelerated nods of Imbruvica in US for patients with certain types of blood cancer Ruchika Sharma7 April 2023 3:30 PM ISTIMBRUVICA is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company and Janssen Biotech, Inc.
Medical Bulletin 1/April/2023 Isra Zaman1 April 2023 3:40 PM ISTHere are the top medical news for the day:CAR T cells improve patient quality of life: StudyChimeric antigen receptor T-cell (CAR-T) therapies are...
CAR T cells improve patient quality of life: Study Isra Zaman1 April 2023 9:15 AM ISTChimeric antigen receptor T-cell (CAR-T) therapies are developed by harvesting a patient's own T cells (the immune system's primary cancer-killing...
Blood test may predict risk of relapse after bone marrow transplant in acute myeloid leukemia patients Dr. Kamal Kant Kohli14 March 2023 8:00 PM ISTResearchers at the National Institutes of Health have devised strategy to predict risk of relapse after bone marrow transplant in acute myeloid...
Vitamin B5 could improve outcomes in patients with a rare type of blood cancer: Study Dr. Kamal Kant Kohli4 March 2023 10:15 AM ISTUK: Vitamin B5, in combination with existing drugs, could improve outcomes in patients with Myelodysplastic syndromes (MDS), a rare type of blood...
